OmniGuide Begins European Commercialization

Friday, October 5, 2007 General News J E 4
CAMBRIDGE, Mass., Sept. 26 OmniGuide, Inc.( today announced that European commercializationhas begun for its flexible CO2 laser fibers. The OmniGuide family of CO2laser fibers and accessories will primarily be utilized for otology,laryngology and head & neck surgery. Additional applications in gynecology,gastroenterology, laparoscopy and bronchoscopy are under development and willbe commercialized over the next year.

"Since the beginning of 2007 over 1000 successful minimally invasivesurgeries have been enabled using our flexible surgical fibers to the benefitof patients across the US. We are thrilled to begin addressing the need forprecision surgical fiber cutting tools in Europe," said Prof. Yoel Fink,OmniGuide co-Founder. "Europe is the second geographical market after theUnited States for the introduction of the surgical product portfolio based onOmniGuide's CO2 fiber technology. Surgeons and patients throughout Europe willbegin to realize the same benefits that our current surgeons have communicatedto us about the OmniGuide system: reduced procedure times, broader treatmentoptions, less invasive surgical treatments and improved surgical technique."

The first European surgical cases were performed by the Department ofOtolaryngology at the CHUV Medical Center in Lausanne, Switzerland led byProf. Monnier. According to primary investigator Dr. Luc Bron, the initialcases of head and neck tumor resection, laryngology and otologic stapedectomywere very successful.

OmniGuide is currently supporting initial European centers through adirect clinical and sales operation from its Cambridge, Massachusettsheadquarters. As the European business expands, alternative support anddistribution alternatives will be evaluated.

About OmniGuide Technology

The OmniGuide OtoBeam, BeamPath and LightPath flexible CO2 laser fibersystems are FDA-cleared and CE Marked devices, and have treated over 1,200patients in approximately 150 U.S. and European medical facilities. CO2 laserenergy offers unparalleled precision and a high degree of control overpenetration into soft tissue. These attributes are critical in otology,laryngology, laparoscopy, GI, head and neck surgery, and pulmonologyprocedures for which there is the potential to damage delicate untargetedstructures. 20,000 CO2 lasers have been deployed in operating rooms throughoutthe world. However, until now, CO2 lasers have limited applications toinvasive surgery due to the absence of a fiber delivery system at theirwavelength of operation.

The key to OmniGuide's technology is a revolutionary photonic bandgapfiber that was originally invented and developed at MIT. The company holds anexclusive license from MIT and has added an extensive portfolio of related USand international patents. The technology was first published in Nature in2002.

For more information, please contact:

Doug Hutchison, VP Sales and Marketing,

SOURCE OmniGuide, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
AUDIO from Medialink and Bayer: Simple, Focused Wa...
NCIIA Announces Launch of 4th Annual Student Biome...